Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals

Clin Diagn Lab Immunol. 1998 Jan;5(1):114-7. doi: 10.1128/CDLI.5.1.114-117.1998.

Abstract

A neutralization enzyme immunoassay (N-EIA) was used to determine the neutralizing serum antibody titers to influenza A/Taiwan/1/86 (H1N1) and Beijing/353/89 (H3N2) viruses after vaccination of 51 human immunodeficiency virus (HIV) type 1-infected individuals and 10 healthy noninfected controls against influenza virus infection. Overall, the N-EIA titers correlated well with the hemagglutination-inhibition (HAI) titers that were observed in the same samples in a previous study (F. P. Kroon, J. T. van Dissel, J. C. de Jong, and R. van Furth, AIDS 8:469-476,1994). The N-EIA appeared to be more sensitive than the HAI test. Significantly more fourfold or higher rises in N-EIA titer and higher mean N-EIA titers occurred in HIV-infected individuals with > or =200 CD4+ cells per microl than in those with <200 CD4+ cells per microl.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • Antibody Formation
  • Antibody-Dependent Enhancement
  • Data Interpretation, Statistical
  • Female
  • HIV Infections / prevention & control*
  • Hemagglutination Inhibition Tests
  • Humans
  • Immunoenzyme Techniques
  • Influenza A virus / immunology*
  • Influenza Vaccines / therapeutic use*
  • Male
  • Methods
  • Middle Aged
  • Neutralization Tests
  • Time Factors
  • Vaccination*

Substances

  • Antibodies, Viral
  • Influenza Vaccines